Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 166 AL 180

Ergothioneine Mediated Neuroprotective Effects in the Nervous System

Saha T, Frisina RD, Zhu X, Park C, Ding B, Walton JP, Bazard P.

Mol Nutr Food Res. 2026 Oct;70(19):e70619. doi: 10.1002/mnfr.70619.

Ketogenic Diet and Neurological Health: A Narrative Review with Natural Language Processing-Assisted Thematic Mapping Using BERTopic

Jin B, Chen Z, Xie R, Liu Y.

Neuropsychiatr Dis Treat. 2026 Oct 10;22:627639. doi: 10.2147/NDT.S627639. eCollection 2026.

NAD(+) signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives

Wang T, Zhou X, Chen X.

Front Neurol. 2026 Sep 30;17:1943801. doi: 10.3389/fneur.2026.1943801. eCollection 2026.

GBA1 Canada initiative (G-can), a pre-competitive, open science platform for GBA1 research

Halder P, Chebon-Bore L, Sommerville EN, Senkevich K, Bayne AN, Pietrantonio I, Tavasoli M, Van Raamsdonk JM, Parent M, Armstrong GA, Sharp M, Laflamme C, McPherson PS, Pandolfo M, Durcan TM, Dupré N, Milnerwood AJ, Trempe JF, Postuma RB, Karamchandani J, Fon EA, Rouleau GA, Gan-Or Z; GBA1 Canada Initiative (G-Can).

J Parkinsons Dis. 2026 Oct 15:1877718X261497542. doi: 10.1177/1877718X261497542. Online ahead of print.

Noninvasive brain stimulation for motor function and quality of life in Parkinson's disease: a systematic review and network meta-analysis

Hu S, Liu J, Wang F, Wang G, Zhi Y, Gao X, Kim D.

J Clin Neurosci. 2026 Oct 15;155:112347. doi: 10.1016/j.jocn.2026.112347. Online ahead of print.

A comprehensive review of the neurobehavioral and neurotoxic effects of 6PPD-Q in fish, rodents, and humans

Ivantsova E, Lu A, Martyniuk CJ.

Neurotoxicol Teratol. 2026 Oct 15;118:107725. doi: 10.1016/j.ntt.2026.107725. Online ahead of print.

Evaluating multivariable clinical prediction models for Parkinson's disease prognosis: A scoping review

Eickholt L, Super M, Fioravante N, Yuan S, Aamodt WW.

Parkinsonism Relat Disord. 2026 Oct 12:109017. doi: 10.1016/j.parkreldis.2026.109017. Online ahead of print.

Bee-Derived Products in Neurodegenerative Diseases: Bioactive Constituents, Redox-Modulating Mechanisms, Evidence, and Translational Perspectives

Garbarek J, Hys O, Woźniak A, Szewczyk-Golec K, Nuszkiewicz J.

Molecules. 2026 Oct 7;31(19):3564. doi: 10.3390/molecules31193564.

GLP-1, GIP, and Glucagon Receptor Agonism at the Obesity-Neurodegeneration Interface: A Narrative Review

Popa E, Popa AE, Poroch V, Schreiner TG, Slanina AM, Poroch M, Hatneanu AM, Ungureanu MI, Petroaie AD, Bacusca AI, Coman EA.

Int J Mol Sci. 2026 Sep 30;27(19):8738. doi: 10.3390/ijms27198738.

Cuproptosis: New Mechanisms Linking Endothelial Dysfunction to Neurodegenerative Diseases and Therapeutic Prospects

Gu T, Wei X, Hua S.

Int J Mol Sci. 2026 Sep 30;27(19):8765. doi: 10.3390/ijms27198765.

Targeting the microbiota-gut-brain axis in Alzheimer's and Parkinson´s disease: recent therapeutic approaches

Gries M, Schäfer KH, Endres K.

Expert Opin Ther Targets. 2026 Oct 22:1-16. doi: 10.1080/14728222.2026.2748747. Online ahead of print.

Neurodegenerative diseases in Sub-Saharan Africa: diagnostic invisibility, biological heterogeneity and a precision-neuroscience agenda

Kipanyula MJ.

Neuroscience. 2026 Oct 16;619:58-74. doi: 10.1016/j.neuroscience.2026.10.026. Online ahead of print.

Gene-based association analysis of depression risk among European ancestry Parkinson's disease patients

Wang H, Paul K, Kusters C, Lill CM, Zhou J, Bronstein J, Ritz B.

Hum Genet. 2026 Oct 17;145(1):88. doi: 10.1007/s00439-026-02877-8.

Recent advances in the management of Lewy body dementia: evaluating progress and future directions

Goldman JG, Wyman K, Kane JP.

Expert Rev Neurother. 2026 Oct 16:1-18. doi: 10.1080/14737175.2026.2749652. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias